3.21.2 html 267 365 1 true 73 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://adamis.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://adamis.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://adamis.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://adamis.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Sheet http://adamis.com/role/CondensedConsolidatedStatementsOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) Sheet http://adamis.com/role/CondensedConsolidatedStatementsOfStockholdersEquityParenthetical CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) Statements 6 false false R7.htm 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://adamis.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 00000008 - Disclosure - Basis of Presentation Sheet http://adamis.com/role/BasisOfPresentation Basis of Presentation Notes 8 false false R9.htm 00000009 - Disclosure - Revenues Sheet http://adamis.com/role/Revenues Revenues Notes 9 false false R10.htm 00000010 - Disclosure - Inventories Sheet http://adamis.com/role/Inventories Inventories Notes 10 false false R11.htm 00000011 - Disclosure - Fixed Assets, net Sheet http://adamis.com/role/FixedAssetsNet Fixed Assets, net Notes 11 false false R12.htm 00000012 - Disclosure - Intangible Assets and Goodwill Sheet http://adamis.com/role/IntangibleAssetsAndGoodwill Intangible Assets and Goodwill Notes 12 false false R13.htm 00000013 - Disclosure - Leases Sheet http://adamis.com/role/Leases Leases Notes 13 false false R14.htm 00000014 - Disclosure - Debt Sheet http://adamis.com/role/Debt Debt Notes 14 false false R15.htm 00000015 - Disclosure - Fair Value of Financial Instruments Sheet http://adamis.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 15 false false R16.htm 00000016 - Disclosure - Commitments and Contingencies Sheet http://adamis.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 00000017 - Disclosure - Common Stock Sheet http://adamis.com/role/CommonStock Common Stock Notes 17 false false R18.htm 00000018 - Disclosure - Stock-based Compensation, Warrants and Shares Reserved Sheet http://adamis.com/role/Stock-basedCompensationWarrantsAndSharesReserved Stock-based Compensation, Warrants and Shares Reserved Notes 18 false false R19.htm 00000019 - Disclosure - Segment Information Sheet http://adamis.com/role/SegmentInformation Segment Information Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://adamis.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Basis of Presentation (Policies) Sheet http://adamis.com/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies 21 false false R22.htm 00000022 - Disclosure - Revenues (Tables) Sheet http://adamis.com/role/RevenuesTables Revenues (Tables) Tables http://adamis.com/role/Revenues 22 false false R23.htm 00000023 - Disclosure - Inventories (Tables) Sheet http://adamis.com/role/InventoriesTables Inventories (Tables) Tables http://adamis.com/role/Inventories 23 false false R24.htm 00000024 - Disclosure - Fixed Assets, net (Tables) Sheet http://adamis.com/role/FixedAssetsNetTables Fixed Assets, net (Tables) Tables http://adamis.com/role/FixedAssetsNet 24 false false R25.htm 00000025 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://adamis.com/role/IntangibleAssetsAndGoodwillTables Intangible Assets and Goodwill (Tables) Tables http://adamis.com/role/IntangibleAssetsAndGoodwill 25 false false R26.htm 00000026 - Disclosure - Leases (Tables) Sheet http://adamis.com/role/LeasesTables Leases (Tables) Tables http://adamis.com/role/Leases 26 false false R27.htm 00000027 - Disclosure - Debt (Tables) Sheet http://adamis.com/role/DebtTables Debt (Tables) Tables http://adamis.com/role/Debt 27 false false R28.htm 00000028 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://adamis.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://adamis.com/role/FairValueOfFinancialInstruments 28 false false R29.htm 00000029 - Disclosure - Stock-based Compensation, Warrants and Shares Reserved (Tables) Sheet http://adamis.com/role/Stock-basedCompensationWarrantsAndSharesReservedTables Stock-based Compensation, Warrants and Shares Reserved (Tables) Tables http://adamis.com/role/Stock-basedCompensationWarrantsAndSharesReserved 29 false false R30.htm 00000030 - Disclosure - Segment Information (Tables) Sheet http://adamis.com/role/SegmentInformationTables Segment Information (Tables) Tables http://adamis.com/role/SegmentInformation 30 false false R31.htm 00000031 - Disclosure - Basis of Presentation (Details Narrative) Sheet http://adamis.com/role/BasisOfPresentationDetailsNarrative Basis of Presentation (Details Narrative) Details http://adamis.com/role/BasisOfPresentationPolicies 31 false false R32.htm 00000032 - Disclosure - Revenues (Details Narrative) Sheet http://adamis.com/role/RevenuesDetailsNarrative Revenues (Details Narrative) Details http://adamis.com/role/RevenuesTables 32 false false R33.htm 00000033 - Disclosure - The following table presents the Company's revenues disaggregated (Details) Sheet http://adamis.com/role/FollowingTablePresentsCompanysRevenuesDisaggregatedDetails The following table presents the Company's revenues disaggregated (Details) Details 33 false false R34.htm 00000034 - Disclosure - Inventories at June 30, 2021 and December 31, 2020 consisted of the following (Details) Sheet http://adamis.com/role/InventoriesAtJune302021AndDecember312020ConsistedOfFollowingDetails Inventories at June 30, 2021 and December 31, 2020 consisted of the following (Details) Details 34 false false R35.htm 00000035 - Disclosure - Inventories (Details Narrative) Sheet http://adamis.com/role/InventoriesDetailsNarrative Inventories (Details Narrative) Details http://adamis.com/role/InventoriesTables 35 false false R36.htm 00000036 - Disclosure - Fixed assets at June 30, 2021 and December 31, 2020 are summarized in the table below (Details) Sheet http://adamis.com/role/FixedAssetsAtJune302021AndDecember312020AreSummarizedInTableBelowDetails Fixed assets at June 30, 2021 and December 31, 2020 are summarized in the table below (Details) Details 36 false false R37.htm 00000037 - Disclosure - Fixed Assets, net (Details Narrative) Sheet http://adamis.com/role/FixedAssetsNetDetailsNarrative Fixed Assets, net (Details Narrative) Details http://adamis.com/role/FixedAssetsNetTables 37 false false R38.htm 00000038 - Disclosure - Intangible assets at June 30, 2021 and December 31, 2020 are summarized in the tables below (Details) Sheet http://adamis.com/role/IntangibleAssetsAtJune302021AndDecember312020AreSummarizedInTablesBelowDetails Intangible assets at June 30, 2021 and December 31, 2020 are summarized in the tables below (Details) Details 38 false false R39.htm 00000039 - Disclosure - Estimated amortization expense of definite-lived intangible assets at June 30, 2021 for each of the five succeeding years and thereafter is as follows: (Details) Sheet http://adamis.com/role/EstimatedAmortizationExpenseOfDefinite-livedIntangibleAssetsAtJune302021ForEachOfFiveSucceedingYearsAndThereafterIsAsFollowsDetails Estimated amortization expense of definite-lived intangible assets at June 30, 2021 for each of the five succeeding years and thereafter is as follows: (Details) Details 39 false false R40.htm 00000040 - Disclosure - The change in the carrying amount of goodwill consisted of the following activity (Details) Sheet http://adamis.com/role/ChangeInCarryingAmountOfGoodwillConsistedOfFollowingActivityDetails The change in the carrying amount of goodwill consisted of the following activity (Details) Details 40 false false R41.htm 00000041 - Disclosure - Intangible Assets and Goodwill (Details Narrative) Sheet http://adamis.com/role/IntangibleAssetsAndGoodwillDetailsNarrative Intangible Assets and Goodwill (Details Narrative) Details http://adamis.com/role/IntangibleAssetsAndGoodwillTables 41 false false R42.htm 00000042 - Disclosure - Leases (Details Narrative) Sheet http://adamis.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://adamis.com/role/LeasesTables 42 false false R43.htm 00000043 - Disclosure - The tables below present the operating and financing lease assets and liabilities recognized on the condensed consolidated balance sheets as of June 30, 2021 and December 31, 2020 (Details) Sheet http://adamis.com/role/TablesBelowPresentOperatingAndFinancingLeaseAssetsAndLiabilitiesRecognizedOnCondensedConsolidatedBalanceSheetsAsOfJune302021AndDecember312020Details The tables below present the operating and financing lease assets and liabilities recognized on the condensed consolidated balance sheets as of June 30, 2021 and December 31, 2020 (Details) Details 43 false false R44.htm 00000044 - Disclosure - The Company's weighted average remaining lease term and weighted average discount rate for operating and financing leases as of June 30, 2021 and December 31, 2020 ar (Details) Sheet http://adamis.com/role/CompanysWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateForOperatingAndFinancingLeasesAsOfJune302021AndDecember312020ArDetails The Company's weighted average remaining lease term and weighted average discount rate for operating and financing leases as of June 30, 2021 and December 31, 2020 ar (Details) Details 44 false false R45.htm 00000045 - Disclosure - The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the unaudited condensed consolidat (Details) Sheet http://adamis.com/role/TableBelowReconcilesUndiscountedFutureMinimumLeasePaymentsDisplayedByYearAndInAggregateUnderNon-cancelableLeasesWithTermsOfMoreThanOneYearToTotalLeaseLiabilitiesRecognizedOnUnauditedCondensedConsolidatDetails The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the unaudited condensed consolidat (Details) Details 45 false false R46.htm 00000046 - Disclosure - Debt (Details Narrative) Sheet http://adamis.com/role/DebtDetailsNarrative Debt (Details Narrative) Details http://adamis.com/role/DebtTables 46 false false R47.htm 00000047 - Disclosure - At June 30, 2021, the outstanding principal maturities of the amended long-term debts were as follows (Details) Sheet http://adamis.com/role/AtJune302021OutstandingPrincipalMaturitiesOfAmendedLong-termDebtsWereAsFollowsDetails At June 30, 2021, the outstanding principal maturities of the amended long-term debts were as follows (Details) Details 47 false false R48.htm 00000048 - Disclosure - The following table sets forth the Company???s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (Details) Sheet http://adamis.com/role/FollowingTableSetsForthCompanysFinancialInstrumentsThatWereMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails The following table sets forth the Company???s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (Details) Details 48 false false R49.htm 00000049 - Disclosure - The following table sets forth a summary of the changes in the fair value of the Company???s Level 3 financial instruments, which are treated as liabilities, as follows: (Details) Sheet http://adamis.com/role/FollowingTableSetsForthSummaryOfChangesInFairValueOfCompanysLevel3FinancialInstrumentsWhichAreTreatedAsLiabilitiesAsFollowsDetails The following table sets forth a summary of the changes in the fair value of the Company???s Level 3 financial instruments, which are treated as liabilities, as follows: (Details) Details 49 false false R50.htm 00000050 - Disclosure - Fair Value of Financial Instruments (Details Narrative) Sheet http://adamis.com/role/FairValueOfFinancialInstrumentsDetailsNarrative Fair Value of Financial Instruments (Details Narrative) Details http://adamis.com/role/FairValueOfFinancialInstrumentsTables 50 false false R51.htm 00000051 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://adamis.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://adamis.com/role/CommitmentsAndContingencies 51 false false R52.htm 00000052 - Disclosure - Common Stock (Details Narrative) Sheet http://adamis.com/role/CommonStockDetailsNarrative Common Stock (Details Narrative) Details http://adamis.com/role/CommonStock 52 false false R53.htm 00000053 - Disclosure - The following summarizes the stock option activity for the six months ended June 30, 2021 below: (Details) Sheet http://adamis.com/role/FollowingSummarizesStockOptionActivityForSixMonthsEndedJune302021BelowDetails The following summarizes the stock option activity for the six months ended June 30, 2021 below: (Details) Details 53 false false R54.htm 00000054 - Disclosure - The following table summarizes the RSUs outstanding at June 30, 2021 (Details) Sheet http://adamis.com/role/FollowingTableSummarizesRsusOutstandingAtJune302021Details The following table summarizes the RSUs outstanding at June 30, 2021 (Details) Details 54 false false R55.htm 00000055 - Disclosure - The following summarizes warrants outstanding at June 30, 2021 and December 31, 2020: (Details) Sheet http://adamis.com/role/FollowingSummarizesWarrantsOutstandingAtJune302021AndDecember312020Details The following summarizes warrants outstanding at June 30, 2021 and December 31, 2020: (Details) Details 55 false false R56.htm 00000056 - Disclosure - At June 31, 2021, the Company has reserved shares of common stock for issuance (Details) Sheet http://adamis.com/role/AtJune312021CompanyHasReservedSharesOfCommonStockForIssuanceDetails At June 31, 2021, the Company has reserved shares of common stock for issuance (Details) Details 56 false false R57.htm 00000057 - Disclosure - Stock-based Compensation, Warrants and Shares Reserved (Details Narrative) Sheet http://adamis.com/role/Stock-basedCompensationWarrantsAndSharesReservedDetailsNarrative Stock-based Compensation, Warrants and Shares Reserved (Details Narrative) Details http://adamis.com/role/Stock-basedCompensationWarrantsAndSharesReservedTables 57 false false R58.htm 00000058 - Disclosure - The following tables present a summary of the Company???s reporting segments for the three months and six months ended June 30, 2021 and 2020, respectively (unaudited) (Details) Sheet http://adamis.com/role/FollowingTablesPresentSummaryOfCompanysReportingSegmentsForThreeMonthsAndSixMonthsEndedJune302021And2020RespectivelyDetails The following tables present a summary of the Company???s reporting segments for the three months and six months ended June 30, 2021 and 2020, respectively (unaudited) (Details) Details 58 false false R59.htm 00000059 - Disclosure - the following segment information is presented for Drug Development and Commercialization; and Compounded Pharmaceuticals. (Details) Sheet http://adamis.com/role/FollowingSegmentInformationIsPresentedForDrugDevelopmentAndCommercializationAndCompoundedPharmaceuticals.Details the following segment information is presented for Drug Development and Commercialization; and Compounded Pharmaceuticals. (Details) Details 59 false false R60.htm 00000060 - Disclosure - Segment Information (Details Narrative) Sheet http://adamis.com/role/SegmentInformationDetailsNarrative Segment Information (Details Narrative) Details http://adamis.com/role/SegmentInformationTables 60 false false R61.htm 00000061 - Disclosure - Subsequent Events (Details Narrative) Sheet http://adamis.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://adamis.com/role/SubsequentEvents 61 false false All Reports Book All Reports admp-10q_063021.htm admp-20210630.xsd admp-20210630_cal.xml admp-20210630_def.xml admp-20210630_lab.xml admp-20210630_pre.xml ex10-1.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 true true